A Leader in Regulatory Affairs Recruiting
A Leader in Regulatory Affairs Recruiting
Mission: Our goal at Dennis Partners is to become the premier Regulatory Affairs recruiting specialist for both our clients and our candidates.
See you in 2019!
Did you know that we're hiring??
This role is for someone who loves to learn and welcomes any opportunity to meet someone new 👇👇👇
indeed.com Over the past 15 years, we have seen the Regulatory Affairs community evolve based upon the globalization of market demands. At Dennis Partners, we exclusively specialize in the placement of professionals from mid-level management through Executive leadership.
Hey friends, we're doing some internal hiring here for two different sales roles. Check them out 👇👇
Sales Development Associate
Executive Search Consultant
"Don't hang up on me; I'm not a bill collector!"
Dennis Partners will be closed for Labor Day Weekend starting Friday 8/31. Feel free to email/call but please be patient as there may be a slight delay in response. We will be back in the office on Tuesday 9/4
When you become best friends with your work colleague #DPDogs
Find out in our latest Regulatory Explainer on the Priority Review Voucher system.
#RegulatoryAffairs #PriorityReview #DrugApprovals
raps.org Since 2007, the US Food and Drug Administration (FDA) has issued a handful of special "priority review" vouchers which allow its recipient to expedite the review of any one of its new drug products. What are these vouchers, why is FDA issuing them and what benefit might they have for society? Find o...
"Of the 5,500 hiring decision-makers polled, 58% said they extend counteroffers to departing employees. Senior managers said they saw employees stay an average of 1.7 years after giving them a counteroffer."
hrdive.com Employers must understand why an employee may be leaving and seek to solve the underlying issues rather than shell out money as a stopgap.
Perfect day for minigolf!
"The roots of this crisis are embedded in the practice of medicine, and prescribing practices that were at times too cavalier," Gottlieb said.
biopharmadive.com Despite some progress made, the agency chief called for further reductions in the number of prescriptions written for opioids.
International Group Pushes for 9 New Drug Labeling, Packaging Guidelines
#RegulatoryAffairs #Packaging #Labeling
drugtopics.com Standardization coming for drug labeling and packaging.
Our office will be closed today to celebrate our nation's independence but we're back in on Thursday!
Scientists Spot Gene Linking Down Syndrome, Early Alzheimer's
#DownsSyndrome #Alzheimers http://ow.ly/kNfQ30kMyof
drugs.com British researchers are zeroing in on the genes that they believe are responsible for early onset Alzheimer's disease in people with Down syndrome.
We've got a big #DPDogs squad today!
Why go it alone?
linkedin.com In my daily conversations with candidates, a recurring topic is whether they should utilize the services of a professional recruiter or apply directly
Regulatory News Headlines for the week!
#WeKnowRegulatory #RegulatoryAffairs #Pharma
linkedin.com The FDA granted accelerated approval to Merck’s Keytruda (pembrolizumab) for the treatment of patients with advanced, PD-L1–positive cervical cancer
Happy Fathers Day weekend! #DPDogs
Another great team building event this week - PICTIONARY
Useful info for our followers who aren't actively in #RegulatoryAffairs
northeastern.edu Interested in the field of regulatory affairs but not sure where to start? Here’s a guide to help you navigate the industry.
FDA says it has approved 496 abbreviated new drug applications (ANDAs) and tentatively approved another 114 ANDAs in Fiscal 2018.
raps.org Eight months into Fiscal 2018, the US Food and Drug Administration (FDA) is on target to approve a similar number of generic drugs as it did the previous year.
In case you missed it... Last week's #Regulatory headlines
linkedin.com Eli Lilly and Incyte Corporation announced that the FDA has approved OLUMIANT (baricitinib) for the treatment of adults with moderately-to-severely
California Life Science Sector Workforce Trends Report. Can you guess what functions are hardest to fill?
“So we’re doing it on the generic side, but we’re also thinking of doing it on the new drug side,” Gottlieb said in an interview on Saturday at ASCO
reuters.com In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines.
It's certainly great news that unemployment is so low, but that also means #hiring top talent is more challenging. Especially in #RegulatoryAffairs according to Boston Business Journal, which states:
Hey everyone - we'll be out of the office tomorrow, but will do our best to respond to emails/calls/texts. Have a good MDW!
linkedin.com Hi folks, I am publishing my blog a day early due to the holiday weekend. Here are the top regulatory stories for this week: On Monday Dova
The gene therapy optimism is promising. Inspiring to see the FDA support innovative pathways like this.
endpts.com In a rallying cry for gene therapy, FDA Commissioner Scott Gottlieb says he's determined to clear the pathway for drug developers in a move to accelerate the first wave of gene therapies pointed to the market. The first therapeutic area to benefit from new surrogate endpoints will be hemophilia, Got...
Big THANK YOU to our Office Manager Veronica Ritchie for an exciting game of Dennis Partners themed Family Feud!
Only a few more hours. What do you think we'll hear?
washingtonpost.com Hint: it's not what Democrats are hoping for.
What do you think will come of this?
statnews.com President Trump is set to deliver a major address on drug prices this week. And perhaps more than with any other president, Washington is wondering: What will he say?
Would you look at this little Buster! Happy Friday from our newest visitor!
Which one is most important for you as a leader or an employee?
linkedin.com What's your reaction when you hear a 5-time Super Bowl winning quarterback state he feels everyone could be more appreciated? Part of it depends on
Are you done working yet?
Our newest recruiter, Leo, has made impressive progress in the past year.
#WeKnowRegulatory #HeKnowsRegulatory #RegulatoryAffairs
Update - White House indefinitely postpones Trump's speech on lowering drug prices.
healthexec.com President Donald Trump has postponed this week’s speech on battling rising prescription drug costs, according to the White House. No future date, time or location has been announced for the speech, previously scheduled for Thursday, April 26.
Two of our more senior canine staffers - sometimes they need to do a bit of one on one #conflictresolution and sometimes they suck up to the boss 😏
Fail to Plan - Plan to Fail
#JobInterview #RegulatoryAffairs #preparation
linkedin.com In the process of planning your next Strategic Career Move, the value of Interview Preparation can never be taken lightly. Too often I find myself
ICYMI: Regulatory News Headlines from last week!
linkedin.com This was a relatively busy week with new draft guidances, new orphan drug designations, two supplemental approvals, and the lifting of a clinical
Super informative AMA from Leah Christl from the FDA on #Biosimilars
#FDA #RegulatoryAffairs #RedditAMA
reddit.com Hello reddit! I’m Leah Christl, and I am the Director of the Therapeutic Biologics and Biosimilars Staff at the Center for Drug Evaluation and...
"Regulatory Trivia for 800, Alex!"
Great team-building Jeopardy covering internal and industry topics yesterday 🙌
If you're reading this post, you should read this blog.
#digitalbrand #reputation #RegulatoryAffairs
www.dennispartners.com Most of us associate the term “brand” with companies or sports figures which market their products or personas. The billions of dollars that are invested each year into building and maintaining these brands demonstrates the importance of branding. As an individual, you have a brand as well. Ther...
How will this impact our industry?
bloomberg.com The Trump administration’s proposed tariffs on thousands of Chinese-manufactured products would target dozens of key products used by drugmakers, as well as medical devices including pacemakers and artificial joints.
Employee edition of #TransformationTuesday
Thanks Leo for being a good sport 👍👍
If you haven't figured it out yet, we love our dogs! Here's today's Friday work crew
#RegulatoryAffairs News Highlights for the week!
This week the FDA officially launched its pilot project to publicly release portions of clinical trial-related summaries from pivotal trials
mmm-online.com The Food and Drug Administration regulates more than a third of the U.S. economy. And its new commissioner, Scott Gottlieb, is trying to shake up how it does so.
|Monday||09:00 - 17:00|
|Tuesday||09:00 - 17:00|
|Wednesday||09:00 - 17:00|
|Thursday||09:00 - 17:00|
|Friday||09:00 - 17:00|
An independent provider of comprehensive, professional in-home senior care.
Cape Cod Home Helpers specializes in providing the best in home health care solutions for seniors and those recuperating from recent illness or injury.
Our mission is to improve the health and well-being of all those in our community.